Comment at FDA Public Meeting on Dietary Supplements Blog Comment at FDA Public Meeting on Dietary Supplements Comment made by TINA.org executive director, Bonnie Patten at the FDA’s public meeting on Responsible Innovation in Dietary Supplements held on May 16, 2019. Thank you for the opportunity to…
FTC, FDA Tackle Misleading Marketing of Dangerous Products to Kids — Again Blog FTC, FDA Tackle Misleading Marketing of Dangerous Products to Kids — Again First, e-liquids. Now, THC edibles. Will energy drinks be next?
TINA.org’s Year in Review 2023 Blog TINA.org’s Year in Review 2023 Here’s what we accomplished in 2023 with your help.
When Privacy Concerns and Deceptive Marketing Issues Intersect Blog When Privacy Concerns and Deceptive Marketing Issues Intersect Why TINA.org supports FTC’s proposed changes to COPPA Rule but pushes for more.
Will Prevagen’s Deceptive Advertising Ever End? Blog Will Prevagen’s Deceptive Advertising Ever End? Eight years after TINA.org alerted regulators, supplement ads continue to convey deceptive and misleading memory improvement claims.
TINA.org’s Year in Review 2019 Blog TINA.org’s Year in Review 2019 It was another successful year outing deceptive marketing on multiple fronts.
TINA.org’s Year in Review 2022 Blog TINA.org’s Year in Review 2022 Here’s what we accomplished in 2022 with your help.
Naturally Flavored with Natural Flavors Blog Naturally Flavored with Natural Flavors Is this iced tea indeed natural?
Prevagen May Have Memory Problems Blog Prevagen May Have Memory Problems TINA.org continues to support FTC, New York in federal court.
Free Speech, Advertising, and Me Blog Free Speech, Advertising, and Me Does free speech protect deceptive advertising?
TINA.org’s Year in Review 2024 Blog TINA.org’s Year in Review 2024 Looking back at our accomplishments.
TINA.org to Nerium: Take Down Questionable Health and Income Claims Blog TINA.org to Nerium: Take Down Questionable Health and Income Claims Watch for #NeriumTruth social media campaign exposing company’s inappropriate health and income claims.
The Danger of Loosely Regulated Supplements Blog The Danger of Loosely Regulated Supplements How we can protect ourselves from the $40-50 billion supplement industry amid a shrinking government?
FTC and State AGs Need to Take Their Relationship to the Next Level Blog FTC and State AGs Need to Take Their Relationship to the Next Level TINA.org files comment concerning coordinated efforts to protect consumers.
When TINA.org Investigations Collide Blog When TINA.org Investigations Collide These brand collabs are far from fab.
Prevagen: The Dismal Facts & Figures that Led to TINA.org’s Objection Blog Prevagen: The Dismal Facts & Figures that Led to TINA.org’s Objection Pending class-action settlement leaves consumers behind.
Prevagen Is Going to the Dogs Blog Prevagen Is Going to the Dogs Second Circuit rules FTC/NY case against Prevagen can proceed.
TINA.org’s Year in Review 2016 Blog TINA.org’s Year in Review 2016 Here’s what we accomplished in 2016 with your help.
Snubbing FTC, MLM Claims It Can Prevent and Treat COVID-19 Blog Snubbing FTC, MLM Claims It Can Prevent and Treat COVID-19 Of all the companies exploiting the pandemic, doTerra stands out as a steadfast recidivist.